Theravance Biopharma (TBPH) FCF Margin (2013 - 2026)
Theravance Biopharma's FCF Margin was -33.60% in Q2 2026, down 827.92 percentage points from 794.33% a year earlier and down 447.63 percentage points from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) FCF Margin (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Theravance Biopharma's FCF Margin was 51.51% through Jun 30, 2026, down 265.58 percentage points year-over-year; for FY2025, it was 221.93%, up 240.37 percentage points from FY2024.
- FCF Margin has now increased for four consecutive years, with a five-year change of +596.79 percentage points (FY2020 to FY2025).
- In earlier years, FCF Margin was -18.43% in FY2024 (+32.91 pp), -51.35% in FY2023 (+313.95 pp), -365.29% in FY2022 (+67.14 pp) and -432.43% in FY2021 (-57.57 pp).
- The Q2 2026 figure marks the lowest quarterly FCF Margin since Q2 2023.
- Compared with a year earlier, FCF Margin was higher in four of the last eight quarters, with an average year-over-year change of +49.78 percentage points.
- The best year-over-year quarter for FCF Margin over five years was Q4 2023 (a gain of 839.95 percentage points); the worst was Q2 2026 (a drop of 827.92 percentage points).
- Per Business Quant data, TBPH's FCF Margin in the three quarters before Q2 2026 was 414.03% (Q1 2026), -13.23% (Q4 2025) and -32.56% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | -33.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -33.60% |
| Mar 31, 2026 | 414.03% |
| Dec 31, 2025 | -13.23% |
| Sep 30, 2025 | -32.56% |
| Jun 30, 2025 | 794.33% |
| Mar 31, 2025 | 279.69% |
| Dec 31, 2024 | -5.82% |
| Sep 30, 2024 | -30.89% |
| Jun 30, 2024 | -31.22% |
| Mar 31, 2024 | -7.67% |
| Dec 31, 2023 | -8.72% |
| Sep 30, 2023 | -15.98% |
| Jun 30, 2023 | -96.65% |
| Mar 31, 2023 | -116.72% |
| Dec 31, 2022 | -848.67% |
| Sep 30, 2022 | -177.34% |
| Jun 30, 2022 | -128.76% |
| Mar 31, 2022 | -204.11% |
| Dec 31, 2021 | -305.73% |
| Sep 30, 2021 | -542.56% |
API Access
Theravance Biopharma FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();